Overview

Cardiomedex is a specialty contract research organization dedicated to cardiovascular diseases. Our company concept is unique and based on the generation of preclinical and early clinical proof-of concept evidence to optimize drug development.

Our company provides a global and translational vision for the biopharmaceutical industry:

Highly specialized expertise in: cardiovascular disorders, cardio-oncology, neurocardiology and dysautonomia
Our clinicians and outstanding scientists create a permanent connection between experimental research and the clinic.

Cardiomedex offers :

Lead optimization: cellular and molecular tools for compound screening and device testing with highly sensitive biosensors using BRET-based technology
Full preclinical services: Proof of concept and safety experiments using customized in vivo, ex vivo and in vitro assays
First in man trials for early clinical proof of concept studies
Clinical trials (phases I to IV) in a dedicated and internationally recognized clinical center for investigation, specializing in the autonomic nervous system and cardiometabolic disorders
Strategic consulting for the drug development process, launch onto the market, therapeutic switching and lifecycle extension of existing drugs.